COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 101 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2017. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,186,389 | +9.3% | 97,825 | +5.1% | 0.00% | 0.0% |
| Q2 2023 | $2,000,397 | +3.9% | 93,085 | +16.0% | 0.00% | 0.0% |
| Q1 2023 | $1,925,605 | +2.1% | 80,267 | -1.3% | 0.00% | 0.0% |
| Q4 2022 | $1,886,346 | +46.5% | 81,308 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $1,288,000 | -9.4% | 80,409 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $1,421,000 | -13.9% | 80,198 | -1.0% | 0.00% | 0.0% |
| Q1 2022 | $1,650,000 | +8.4% | 81,034 | -0.5% | 0.00% | – |
| Q4 2021 | $1,522,000 | -4.5% | 81,462 | +0.9% | 0.00% | -100.0% |
| Q3 2021 | $1,594,000 | -8.7% | 80,728 | +9.4% | 0.00% | 0.0% |
| Q2 2021 | $1,745,000 | -24.4% | 73,817 | -24.1% | 0.00% | 0.0% |
| Q1 2021 | $2,307,000 | +1888.8% | 97,316 | +1573.2% | 0.00% | – |
| Q4 2020 | $116,000 | -5.7% | 5,816 | -0.9% | 0.00% | – |
| Q3 2020 | $123,000 | -5.4% | 5,867 | -20.9% | 0.00% | – |
| Q2 2020 | $130,000 | +39.8% | 7,418 | +30.1% | 0.00% | – |
| Q1 2020 | $93,000 | -36.3% | 5,702 | -19.9% | 0.00% | – |
| Q4 2019 | $146,000 | +114.7% | 7,123 | +21.2% | 0.00% | – |
| Q3 2019 | $68,000 | -12.8% | 5,879 | 0.0% | 0.00% | – |
| Q2 2019 | $78,000 | -2.5% | 5,879 | +12.1% | 0.00% | – |
| Q1 2019 | $80,000 | -12.1% | 5,245 | 0.0% | 0.00% | – |
| Q4 2018 | $91,000 | +28.2% | 5,245 | +7.7% | 0.00% | – |
| Q3 2018 | $71,000 | -38.8% | 4,871 | 0.0% | 0.00% | – |
| Q2 2018 | $116,000 | +3.6% | 4,871 | +11.2% | 0.00% | – |
| Q1 2018 | $112,000 | -3.4% | 4,379 | -29.9% | 0.00% | – |
| Q4 2017 | $116,000 | +96.6% | 6,245 | +11.4% | 0.00% | – |
| Q3 2017 | $59,000 | -14.5% | 5,605 | 0.0% | 0.00% | – |
| Q2 2017 | $69,000 | +43.8% | 5,605 | +20.4% | 0.00% | – |
| Q1 2017 | $48,000 | -36.0% | 4,655 | -1.9% | 0.00% | – |
| Q4 2016 | $75,000 | +74.4% | 4,744 | +96.4% | 0.00% | – |
| Q3 2016 | $43,000 | +53.6% | 2,416 | 0.0% | 0.00% | – |
| Q2 2016 | $28,000 | – | 2,416 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |